Mila Blooms Intervention Study



Status:Completed
Conditions:Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:12 - 19
Updated:10/2/2013
Start Date:April 2011
End Date:August 2013
Contact:Sharnail Bazemore
Email:sharnail.bazemore@duke.edu
Phone:919-684-2340

Use our guide to learn which trials are right for you!


This study is focused on the development and pilot/feasibility testing of a smartphone
application to promote a healthy diet, increase physical activity, and prevent weight gain
in adolescent survivors of childhood cancer.


While successful advancements in treatment for childhood Acute Lymphoblastic Leukemia (ALL)
have resulted in a growing cohort of survivors, these survivors are at risk for a number of
long-term health problems. This study proposes to develop and conduct feasibility testing
for a smartphone application that would deliver a health behavior intervention to this
population.

A formative phase focused on intervention and software development will be followed by a
pilot/feasibility test of the intervention. Participants in the intervention will receive a
customized study-designed mobile phone app with a social networking component in which users
will be able to support one another. They will also receive personal support from a health
counselor to help set goals and discuss areas of concern.

Inclusion Criteria:

- Participants must speak & read/write fluent English;

- Adolescent must be between 12 and 19 years of age;

- Adolescent must have a previous diagnosis of childhood Acute Lymphoblastic Leukemia;

- Adolescent must be "off-therapy" (i.e., not in active or maintenance phase of cancer
therapy) for at least 2 years;

- Adolescent must be cleared by his/her physician to participate (defined by obtaining
a score of 80 or greater on the Karnofsky Scale as determined by their physician);

- Participants must have a working phone number;

- Adolescents must live at home with parents in order to facilitate parent involvement
via support materials.

Exclusion Criteria:

- Physician reports that the patient has deficits in neurocognitive functioning that
would preclude him/her from participating in a cognitive-oriented intervention;
We found this trial at
1
site
?
mi
from
Durham, NC
Click here to add this to my saved trials